+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nocturia Drug"

Nocturia Drugs - Global Strategic Business Report - Product Thumbnail Image

Nocturia Drugs - Global Strategic Business Report

  • Report
  • May 2024
  • 192 Pages
  • Global
From
Nocturia - Pipeline Insight, 2024 - Product Thumbnail Image

Nocturia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Nocturia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Nocturia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Nocturia - Pipeline Review, H2 2020 - Product Thumbnail Image

Nocturia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 45 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Nocturia is a condition characterized by frequent nighttime urination. It is often treated with drugs that act on the central nervous system (CNS). These drugs work by reducing the amount of urine produced at night, allowing the patient to sleep through the night without having to get up to urinate. Common CNS drugs used to treat nocturia include anticholinergics, alpha-blockers, and diuretics. Anticholinergics work by blocking the action of acetylcholine, a neurotransmitter that stimulates the bladder. Alpha-blockers work by blocking the action of adrenaline, which can cause the bladder to contract. Diuretics work by increasing the amount of urine produced, allowing the patient to urinate more frequently during the day and less at night. Companies in the nocturia drug market include Pfizer, Merck, Novartis, and AstraZeneca. Show Less Read more